(Q36884461)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17635745%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

review article

1 reference

title

Erythropoiesis-stimulating agent hyporesponsiveness (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17635745%20AND%20SRC:MED&resulttype=core&format=json

erythropoiesis-stimulating agent

2 January 2020

main subject

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17635745%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

author name string

Carol A Pollock

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17635745%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Iain C Macdougall

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17635745%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

publication date

1 August 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17635745%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17635745%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

volume

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17635745%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17635745%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

page(s)

321-330

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17635745%20AND%20SRC:MED&resulttype=core&format=json

Trends in intravenous iron use among dialysis patients in the United States (1994-2002).

2 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2007.00810.X

Iron and the sex difference in heart disease risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2007.00810.X

Iron therapy, advanced oxidation protein products, and carotid artery intima-media thickness in end-stage renal disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2007.00810.X

Administration of parenteral iron and mortality among hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2007.00810.X

Time-dependent associations between iron and mortality in hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2007.00810.X

Predictors of erythropoietin responsiveness in chronic hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2007.00810.X

Clinical factors influencing sensitivity and response to epoetin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2007.00810.X

Characteristics and effects of inflammation in end-stage renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2007.00810.X

Inflammation in end-stage renal failure: could it be treated?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2007.00810.X

Presence of a failed kidney transplant in patients who are on hemodialysis is associated with chronic inflammatory state and erythropoietin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2007.00810.X

Relationship among catheter insertions, vascular access infections, and anemia management in hemodialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2007.00810.X

Hyporesponsiveness to recombinant human erythropoietin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2007.00810.X

Hyporesponsiveness to erythropoietic therapy due to chronic inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2007.00810.X

Is hepcidin a link between anemia, inflammation and liver function in hemodialyzed patients?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2007.00810.X

Vitamin E-bonded hemodialyzer improves atherosclerosis associated with a rheological improvement of circulating red blood cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2007.00810.X

Pentoxifylline improves hemoglobin levels in patients with erythropoietin-resistant anemia in renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2007.00810.X

Effects of pentoxifylline on the haematologic status in anaemic patients with advanced renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2007.00810.X

Randomized, crossover study of the effect of vitamin C on EPO response in hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2007.00810.X

Efficacy and safety of oral versus intravenous ascorbic acid for anaemia in haemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2007.00810.X

Effects of vitamin C infusion and vitamin E-coated membrane on hemodialysis-induced oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2007.00810.X

Factors influencing erythropoietin compliance in peritoneal dialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2007.00810.X

Adequacy of dialysis reduces the doses of recombinant erythropoietin independently from the use of biocompatible membranes in haemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2007.00810.X

Managing erythropoietin hyporesponsiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2007.00810.X

Effects of Parathyroidectomy on Iron Homeostasis and Erythropoiesis in Hemodialysis Patients with Severe Hyperparathyroidism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2007.00810.X

Elderly patients on chronic hemodialysis with hyperparathyroidism: increase of hemoglobin level after intravenous calcitriol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2007.00810.X

Folic acid deficiency modifies the haematopoietic response to recombinant human erythropoietin in maintenance dialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2007.00810.X

Role of folate deficiency on erythropoietin resistance in pediatric and adolescent patients on chronic dialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2007.00810.X

Resistance to erythropoietin in iron-overloaded haemodialysis patients can be overcome by ascorbic acid administration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2007.00810.X

Debate forum: levocarnitine therapy is rational and justified in selected dialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2007.00810.X

Debate forum: carnitine supplements have not been demonstrated as effective in patients on long-term dialysis therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2007.00810.X

Cellular mechanism of resistance to erythropoietin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2007.00810.X

Management of disease-related anemia in patients with multiple myeloma or chronic lymphocytic leukemia: epoetin treatment recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2007.00810.X

Erythropoietin-induced, antibody-mediated pure red cell aplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2007.00810.X

Treatment of erythropoietin-induced pure red cell aplasia: a retrospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2007.00810.X

Relationship between Resistance to Erythropoietin and High Anomalous Hemoglobin Levels in Hemodialysis Patients with Beta-Thalassemia Minor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2007.00810.X

Obscure gastrointestinal bleeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2007.00810.X